Cargando…
The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study
Antibiotics have served humankind through their use in modern medicine as effective treatments for otherwise fatal bacterial infections. Teixobactin is a first member of newly discovered natural antibiotics that was recently identified from a hitherto-unculturable soil bacterium, Eleftheria terrae,...
Autores principales: | Hussein, Maytham, Karas, John A., Schneider-Futschik, Elena K., Chen, Fan, Swarbrick, James, Paulin, Olivia K. A., Hoyer, Daniel, Baker, Mark, Zhu, Yan, Li, Jian, Velkov, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253363/ https://www.ncbi.nlm.nih.gov/pubmed/32457238 http://dx.doi.org/10.1128/mSystems.00077-20 |
Ejemplares similares
-
Linearized teixobactin is inactive and after sequence enhancement, kills methicillin‐resistant Staphylococcus aureus via a different mechanism
por: Wu, Qianhui, et al.
Publicado: (2022) -
Untargeted metabolomics to evaluate polymyxin B toxicodynamics following direct intracerebroventricular administration into the rat brain
por: Hussein, Maytham, et al.
Publicado: (2022) -
Cysteines and Disulfide-Bridged Macrocyclic Mimics of Teixobactin Analogues and Their Antibacterial Activity Evaluation against Methicillin-Resistant Staphylococcus Aureus (MRSA)
por: Malkawi, Ruba, et al.
Publicado: (2018) -
Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against Acinetobacter baumannii: A Metabolomic Study
por: Hussein, Maytham, et al.
Publicado: (2022) -
Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens
por: Hussein, Maytham, et al.
Publicado: (2020)